Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universitat Autónoma De Barcelona has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being reviewed by 1 distinct examiner, ZEMAN, MARY K. This individual is the busiest examiner in the portfolio, managing 1 busiest examiner pending action.
The prosecution is concentrated within 1 distinct art unit. This suggests that the pending biotechnology technology falls under a specific technical group at the patent office. Since 1 distinct examiner handles the only pending action, the applicant's progress is tied directly to the review style of ZEMAN, MARY K.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZEMAN, MARY K | 1 | 58.9% | +34.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17915155 | REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS | ZEMAN, MARY K | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17915155 | REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS | ZEMAN, MARY K | 1686 | §112 | Final Rejection | — | Pending | Sep 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversitat Autónoma De Barcelona has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Mary K Zeman has the most, with 1 of Universitat Autónoma De Barcelona's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
